Terms Defined Elsewhere Clause Samples

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Bylaws Capitalization Date Change of Recommendation Charter 3.2 5.2(a) 7.2(d) (i)(F) 3.1 Closing 2.1 Closing Date Company Company Approvals Company Disclosure Letter Company Personal Information Company Recommendation Company Tax Representation Letter Continuation Period D&O Insurance Delisting Period Effective Time Exchange Fund FDA FDA Licenses Fundamental Action Governmental Antitrust Entity Interim Period Legal Restraint Material Contract Material Customer Material Vendor Merger Merger Sub Non-Wholly Owned Subsidiary Notice of Redemption Notice Notice Period Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality Agreement Potential Purchasers Potential Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) 7.3(a) -2- Stock Ownership Rep Support Agreement Surviving Corporation Tax Representation Letters Third-Party Consents 6.8 Recitals 2.3 7.18(c) 7.8

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Agreement Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Applicable Date 4.5(a) Book-Entry Shares 3.3(b)(ii) Certificate of Merger 2.2(b) Certificates 3.3(b)(i) Change of Control Amendment 6.23(c)(ii) Change of Control Amendment Consent Fee 6.23(c)(ii) Closing 2.2(a) Closing Date 2.2(a) Code Recitals Company Preamble Company 401(k) Plan 6.9(f) Company Affiliate 9.10 Company Alternative Acquisition Agreement 6.3(d)(iv) Company Board Recitals Company Board Recommendation 4.3(a) Company Capital Stock 4.2(a) Company Change of Recommendation 6.3(d)(vii) Company Common Stock Recitals Company Contracts 4.19(b) Company Designees 2.7(a) Company Designated Stockholder Recitals Company Disclosure Letter Article IV Company Employee 6.9(b) Company FA 4.22 Company Independent Petroleum Engineers 4.17(a) Company Intellectual Property 4.14(a) Company Material Adverse Effect 4.1 Company Material Leased Real Property 4.15 Company Material Real Property Lease 4.15 Company Owned Real Property 4.15 Company Permits 4.9(a) Company Preferred Stock 4.2(a) Company Related Party Transaction 4.24 Company Reserve Report 4.17(a) Company Restructuring Transactions Recitals Company SEC Documents 4.5(a) Company Senior Notes Recitals Company Stakeholders’ Pro Forma Equity Percentage 5.22 Company Stock Award 3.2(a) Company Stockholders Meeting 4.4 Company Tax Certificate 6.18(b) Confidentiality Agreement 6.7(b) Creditors’ Rights 4.3(a) days 9.4(e) Designated Stockholder Support Agreement Recitals DGCL 2.1 Dismissal Order 6.24(a)(v) D&O Insurance 6.10(d) DTC 3.3(b)(ii) e-mail 9.3 Effective Time 2.2(b) Eligible Shares 3.1(b)(i) Exchange Agent 3.3(a) Exchange Consideration 6.23(a) Exchange Fund 3.3(a) Exchange Offer Recitals Exchange Offer Expiration Date 6.23(c) Exchange Prospectus 4.8 Exchange Ratio 3.1(b)(i) Exchange Registration Statement 4.8 Excluded Employees 6.9(b) Excluded Shares 3.1(b)(iii) GAAP 4.5(b) HSR Act 4.4 Indemnified Liabilities 6.10(a) Indemnified Persons 6.10(a) Involuntary Insolvency Event Date 6.24(a)(v) Joint Proxy Statement 4.4 Letter of Transmittal 3.3(b)(i) made available 9.4(e) Material Company Insurance Policies 4.20 Material Parent Insurance Policies 5.20 Measurement Date 4.2(a) Merger Recitals Merger Consideration 3.1(b)(i) Merger Registration Statement 4.8 Merger Sub Preamble Merger Sub Board Recitals Minimum Participation Condition 6.23(a) New Financing 6.22 Non-Cancelled Sh...

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “401(k) Plan” Section 6.12 “After Consultation” Section 5.2(b) “Agreement” Introduction “Appointment Date” Section 5.1 “Appointment Time” Section 1.3 “Appraisal Rights” Section 2.3(a) “Assignee” Section 9.13 “Balance Sheet Date” Section 3.8(a) “Bankruptcy Claims/Interest Section 3.25(b) “Bankruptcy Confirmation Order” Section 3.25 “Base Premium” Section 6.6(d) “Benefit Plans” Section 3.11(a) “Certificate of Merger” Section 1.5 “Certificates” Section 2.2(b) “Closing” Section 1.6 “Closing Date” Section 1.6 “Code” Section 2.2(e) “Common Stock” Section 3.2(a) “Company” Introduction “Company Agreements” Section 3.5(a) “Company Board of Directors” Recitals “Company Bylaws” Section 1.3(b) “Company Certificate” Section 1.3(b) “Company Change in Recommendation” Section 5.3(b) “Company Collective Bargaining Agreement” Section 3.16(a) “Company Disclosure Schedule” Article III “Company Financial Advisor” Section 3.20 “Company Governing Documents” Section 1.3(b) “Company IP Agreements” Section 3.15(d) “Company Material Contract” Section 3.13 “Company Options” Section 2.5(a) “Company Permits” Section 3.17(b) “Company Recommendation” Section 5.3(a) “Company Rights” Section 3.2(a) “Company Rights Agreement” Section 3.2(a) “Company Scheduled Agreements” Section 3.5(a) “Company SEC Documents” Section 3.6(a)

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: A&R Company Bylaws Section 2.3(a) A&R Company Charter Section 2.3(a) A&R Company OP Partnership Agreement Section 2.3(b) Acceptable Confidentiality Agreement Section 7.4(b)(i) Acquisition Agreement Section 7.4(a) Agreement Preamble Book-Entry Share Section 3.1(a)(ii) Certificate Section 3.1(a)(ii) Certificate of Limited Partnership Section 4.1(c) Certificate of Partnership Merger Section 2.1(d)(ii) Change in Company Recommendation Section 7.4(b)(iii) Change in Parent Recommendation Section 7.4(b)(iii) Chosen Court Section 10.7(b) Closing Section 2.2 Closing Date Section 2.2 Code Recitals Company Preamble Company 401(k) Plan Section 4.14(b) Company Articles of Merger Section 2.1(a)(ii) Company Board Recitals Company Board Designees Section 7.21 Company Bylaws Section 4.1(c) Company Certificate of Merger Section 2.1(a)(ii) Company Charter Section 4.1(c) Company Common Stock Recitals Company Data Partners Section 4.22(a) Company Development Properties Section 4.12(g) Company Development Property Section 4.12(g) Company Disclosure Schedule Article IV Company Employee Programs Section 4.14(a) Company Equity Award Consideration Section 3.2(e) Company Governing Documents Section 4.1(c) Company LLC Agreement Section 2.3(a) Company Merger Section 2.1(a)(i) Company Merger Certificates Section 2.1(a)(ii) Company Merger Effective Time Section 2.1(a)(ii) Company OP GP Recitals Company Parties Preamble Company Preferred Stock Section 4.3(a) Company Privacy Policy Section 4.22(a) Company Privacy Requirements Section 4.22(a) Company Properties Section 4.12(a) Company Recommendation Section 4.2(b) Company SEC Reports Section 4.8(a) Company Stockholder Approval Section 4.18 Company Stockholder Meeting Section 7.1(c) Company Subsidiaries Section 4.1(b) Company Subsidiary Section 4.1(b) Company Tax Protection Agreement Section 6.1(x) Consent Solicitations Section 7.19(b) Continuing Employee Section 7.8(a) Continuing Employees Section 7.8(a) Contribution Section 2.1(c)(i) Contribution and Issuance Effective Time Section 2.1(c)(ii) Debt Offer Documents Section 7.19(b) Deemed Liquidation Section 7.9(a) DGCL Section 2.1(b)(i) DLLCA Section 2.1(a)(i) Drop Dead Date Section 9.1(b)(iv) DRULPA Section 2.1(d)(i) DSOS Section 2.1(a)(ii) Encumbrances Section 4.12(a) Exchange Agent Section 3.3(a) Exchange Fund Section 3.3(a) Exchange Ratio Section 3.1(a)(ii) Extra Space Merger Sub Preamble Extra Space OP Mer...

Terms Defined Elsewhere. The following terms are defined herein in the sections identified below:

Terms Defined Elsewhere. The following terms are defined in this Agreement as follows: “Agreement” Preamble

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: Acquisition 7.3(d) Agreement Preamble Apogent Preamble Apogent Balance Sheet 3.1(d)(iv) Apogent Benefit Plans 3.1(i)(i) Apogent Bylaws 3.1(a)(ii) Apogent Charter 3.1(a)(ii) Apogent Common Stock 2.1 Apogent Disclosure Schedule 3.1 Apogent Leased Real Property 3.1(r) Apogent Material Contract 3.1(q)(i) Apogent Option 2.1(d) Apogent Organizational Documents 3.1(a)(ii) Apogent Owned Real Property 3.1(r) Apogent Permits 3.1(g)(i) Apogent Preferred Stock 3.1(b)(i) Apogent Purchase Plan 2.1(d) Apogent Restricted Stock Unit 5.11(a)(ii) Apogent Rights 3.1(b)(i) Apogent Rights Agreement 3.1(b)(i) Apogent SEC Documents 3.1(d)(i) Apogent Shareholder Approval 3.1(c)(iii) Apogent Shareholders’ Meeting 5.1(b) Apogent Significant Subsidiaries 3.1(a)(iii) Apogent Stock Plans 3.1(b)(i) Apogent Subsidiary Organizational Documents 3.1(a)(ii) Apogent Termination Fee 7.3(a) Apogent Third Party Bidder 7.3(a)(i) Applicable Laws 3.1(g)(ii) Approval 3.1(i)(ii) Articles of Merger 1.3 Benefit Continuation Period 5.11(c) Benefit Plans 3.1(i)(i) CDA 4.2(c)(i) Certificates 2.2(b) Change of Recommendation 4.2(d)(ii) Closing 1.2 Closing Date 1.2 Code Recitals DFI 1.3 Effect 8.3(k) Effective Time 1.3 ERISA 3.1(i)(i) ERISA Affiliate 3.1(i)(v) Exchange Act 3.1(c)(v)(B)(2) Exchange Agent 2.2(a) (a) Exchange Ratio 2.1(a) FDA 3.1(g)(i)